Long-term efficacy and safety of low-dose rituximab strategy in neuromyelitis optica spectrum disorder: a retrospective cohort study on treatment compliance and clinical outcomes
Our findings support the long-term efficacy and safety of low-dose RTX strategy in treating NMOSD, highlighting the crucial role of treatment compliance in achieving favorable clinical outcomes.
Authors
- Hongzeng Li
- Cong Zhao (ORCID: https://orcid.org/0000-0002-6678-2602)
- Rui Zhang (ORCID: https://orcid.org/0000-0002-0897-1026)
- Jun Guo (ORCID: https://orcid.org/0000-0001-8053-881X)
- Yi Li (ORCID: https://orcid.org/0000-0003-0392-6661)
- Daidi Zhao
- Yao Wang
- Zonghao Pan (ORCID: https://orcid.org/0000-0001-7570-2902)
Institutions
- Air Force General Hospital PLA (CN)
- Tang Du Hospital (CN)
- First Affiliated Hospital of Henan University (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1186/s13023-025-03770-9
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province